China Pharma Holdings Inc (CPHI) — Net Asset Quality Index
China Pharma Holdings Inc (CPHI) has a Net Asset Quality Index of 53.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $15.98 Million minus total liabilities of $7.49 Million yields net assets of $8.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check China Pharma Holdings Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
China Pharma Holdings Inc Net Asset Quality Index Over Time (2001–2024)
This chart shows how China Pharma Holdings Inc's Net Asset Quality Index has evolved across 24 annual periods from 2001 to 2024. As of September 2025, the index stands at 53.1%, representing net assets of $8.49 Million against total assets of $15.98 Million USD. See CPHI working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for China Pharma Holdings Inc (2001–2024)
The table below presents the year-by-year Net Asset Quality Index for China Pharma Holdings Inc from 2001 to 2024, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is China Pharma Holdings Inc worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 52.0% | $7.75 Million | $14.89 Million | $7.14 Million | ▲ +6.8 pp |
| 2023 | 45.3% | $7.45 Million | $16.47 Million | $9.01 Million | ▲ +21.1 pp |
| 2022 | 24.1% | $4.29 Million | $17.78 Million | $13.49 Million | ▼ -2.4 pp |
| 2021 | 26.6% | $6.02 Million | $22.65 Million | $16.63 Million | ▼ -11.3 pp |
| 2020 | 37.9% | $8.00 Million | $21.12 Million | $13.11 Million | ▼ -3.6 pp |
| 2019 | 41.5% | $9.24 Million | $22.24 Million | $13.00 Million | ▼ -25.0 pp |
| 2018 | 66.6% | $30.20 Million | $45.38 Million | $15.18 Million | ▼ -5.3 pp |
| 2017 | 71.8% | $43.07 Million | $59.95 Million | $16.88 Million | ▼ -3.2 pp |
| 2016 | 75.0% | $58.91 Million | $78.52 Million | $19.61 Million | ▲ +0.3 pp |
| 2015 | 74.7% | $72.64 Million | $97.22 Million | $24.58 Million | ▼ -5.7 pp |
| 2014 | 80.4% | $106.25 Million | $132.08 Million | $25.83 Million | ▼ -3.9 pp |
| 2013 | 84.3% | $132.94 Million | $157.61 Million | $24.67 Million | ▼ -6.6 pp |
| 2012 | 91.0% | $148.52 Million | $163.24 Million | $14.72 Million | ▼ -0.1 pp |
| 2011 | 91.1% | $142.48 Million | $156.39 Million | $13.91 Million | ▲ +1.6 pp |
| 2010 | 89.5% | $117.94 Million | $131.75 Million | $13.81 Million | ▼ 0.0 pp |
| 2009 | 89.6% | $90.40 Million | $100.94 Million | $10.54 Million | ▼ -3.0 pp |
| 2008 | 92.6% | $69.87 Million | $75.47 Million | $5.60 Million | ▲ +1.6 pp |
| 2007 | 91.0% | $39.76 Million | $43.71 Million | $3.94 Million | ▲ +17.9 pp |
| 2006 | 73.1% | $20.85 Million | $28.51 Million | $7.66 Million | ▲ +81408.8 pp |
| 2005 | -81335.7% | $-68.32K | $84.00 | $68.41K | ▲ +0.0 pp |
| 2004 | -81335.7% | $-68.32K | $84.00 | $68.41K | ▼ -81089.9 pp |
| 2003 | -245.8% | $-733.96K | $298.63K | $1.03 Million | ▼ -112.7 pp |
| 2002 | -133.0% | $-566.35K | $425.67K | $992.02K | ▲ +0.0 pp |
| 2001 | -133.0% | $-566.35K | $425.67K | $992.02K | — |